loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 22311 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 PLERIXAFOR (1)

filter

01 GENZYME (1)

filter

01 SOLUTION;SUBCUTANEOUS (1)

filter

01 24MG/1.2ML (20MG/ML) (1)

filter

01 USA (1)

URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
24MG/1.2ML (20MG/ML)
MOZOBIL
USA
22311
2008-12-15
RX
Sanofi Company Banner

Cophex 2024

Not Confirmed

envelop Contact Supplier

Looking for CTD TGA MCC DOSSIER APPLICATION 22311

Looking for CTD TGA MCC DOSSIER APPLICATION 22311 1

19

Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their notable products is PLERIXAFOR, with a corresponding application number 22311 and regulatory information .

proudly manufactured in the

approval since 2008-12-15

Sanofi's MOZOBIL SOLUTION;SUBCUTANEOUS, medication with 24MG/1.2ML (20MG/ML) of PLERIXAFOR.

Post Enquiry
POST ENQUIRY